These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2005-000091-40 Pivotal Study to Evaluate the Efficacy and Safety of Dermal - Living Skin Replacement (Dermal – LSR) in the Treatment of Chronic Diabetic Foot Ulcers 2007-11-02 due-trials
Listed as ongoing, but also has a completion date 2007-003331-23 A six-month double-blind, randomized, placebo-controlled study investigating the safety and tolerability of deferiprone in participants with Friedreich's ataxia 2009-07-09 bad-data
Listed as ongoing, but also has a completion date 2009-010865-22 An open-label, single treatment, safety and efficacy, long-term study of deferiprone in subjects with Friedreich's ataxia. 2011-03-02 bad-data
Reported results 2012-000845-11 A randomized, double-blind, placebo-controlled trial of deferiprone in patients with pantothenate kinase-associated neurodegeneration (PKAN) 2016-10-21 due-trials
Completed, but no date Terminated 2013-002181-39 The efficacy and safety of Ferriprox® for the treatment of bad-data
Reported results 2014-001427-79 Long-term Safety and Efficacy Study of Deferiprone in Patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN) 2018-03-16 due-trials
Completed, but no date Terminated 2014-005685-30 Long-term safety and efficacy study of Ferriprox® for the treatment of transfusional iron overload in patients with sickle cell disease or other anemias. bad-data
Not reported 2015-004344-19 A Dose-Ranging Study of the Efficacy, Safety, and Pharmacokinetics of Deferiprone Delayed Release Tablets in Patients with Parkinson’s Disease 2019-09-04 due-trials
Completed, but no date 2018-004016-22 Safety and acceptability of deferiprone delayed release tablets in patients with systemic iron overload bad-data